The last stage of multiple myeloma, according to one common understanding and as indicated by the provided information, is stage 3.
Understanding Multiple Myeloma Staging
Multiple myeloma is a type of cancer that affects plasma cells, a type of white blood cell found in bone marrow. Like many cancers, it is classified into stages to describe how advanced the disease is. Staging helps doctors determine prognosis and treatment options. While different staging systems exist, they generally aim to assess factors like tumor burden, kidney function, calcium levels, and the presence of bone lesions.
Stage 3: The Final Stage
Based on the provided reference, in multiple myeloma cases, stage 3 is the terminal stage. This stage signifies advanced disease progression.
Key characteristics often associated with this advanced stage, as noted:
- It can also be referred to as the distant stage, which means the cancer has spread beyond its initial location in the bone marrow to other parts of the body.
- Even with treatment, the 5-year relative survival rate for distant multiple myeloma is approximately 57%.
Stage 3 generally represents the most extensive form of the disease, often involving significant damage to bones, severe anemia, high calcium levels, and impaired kidney function.
